The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The Vi Capsular Polysaccharide Prevents Complement Receptor 3-Mediated Clearance of Salmonella enterica Serotype Typhi
Open accessAbstract
Capsular polysaccharides are important virulence factors of invasive bacterial pathogens. Here we studied the role of the virulence (Vi) capsular polysaccharide of Salmonella enterica serotype Typhi (S. Typhi) in preventing innate immune recognition by complement. Comparison of capsulated S. Typhi with a noncapsulated mutant (ΔtviBCDE vexABCDE mutant) revealed that the Vi capsule interfered with complement component 3 (C3) deposition. Decreased complement fixation resulted in reduced bacterial binding to complement receptor 3 (CR3) on the surface of murine macrophages in vitro and decreased CR3-dependent clearance of Vi capsulated S. Typhi from the livers and spleens of mice. Opsonization of bacteria with immune serum prior to intraperitoneal infection increased clearance of capsulated S. Typhi from the liver. Our data suggest that the Vi capsule prevents CR3-dependent clearance, which can be overcome in part by a specific antibody response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several factors, most prominently the Vi-capsular polysaccharide, enable S. Typhi to evade innate immune responses (for example by enabling evasion of detection by complement [51]) and to establish systemic infections without clinical sepsis [40,52].”
From Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans (2015) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of typhoid fever.
(2004) · Europe PMC (PubMed Central) · Cited by 1,965
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
Parkhill, J., Dougan, G., James, K. D., Thomson, N. R., Pickard, D., Wain, J., Churcher, C., Mungall, K. L., Bentley, S. D., Holden, M. T. G., et al. (2001) · Nature · doi:10.1038/35101607 · Cited by 1,271 · cited 4×
“The viaB locus of S. Typhi is located on a 134-kb DNA region, termed Salmonella pathogenicity island 7 (SPI-7) (24).”
BackgroundInfluentialComplement: a unique innate immune sensor for danger signals
GASQUE, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.011 · Cited by 552 · cited 4×
“Detection of the lipopolysaccharide (LPS) O antigen of Gram-negative bacteria by C3 is a pattern recognition event that initiates the alternative pathway of complement activation (9, 38).”
BackgroundInfluentialPROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER
Klugman, K., Koornhof, H., Schneerson, R., Cadoz, M., Gilbertson, I., Robbins, J., Schulz, D., & Armand, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91316-x · Cited by 307 · cited 1×
“Typhi involves an extracellular phase that renders the pathogen susceptible to Fc receptor-mediated phagocytosis and/or serum-mediated killing (19, 29, 32).”
BackgroundMarques, M. B., Kasper, D. L., Pangburn, M. K., & Wessels, M. R. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.3986-3993.1992 · Cited by 270 · cited 1×
“The finding that the Vi capsule prevents complement deposition reinforces the concept that inhibition of C3 fixation is a virulence strategy shared by a number of invasive capsulated bacterial pathogens, including extraintestinal pathogenic Escherichia coli (15, 35), Klebsiella pneumoniae (1), Neisseria meningitidis (…”
BackgroundHorwitz, M. A., & Silverstein, S. C. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109663 · Cited by 262 · cited 3×
“coli isolates associated with extraintestinal infections (2, 7, 10, 15, 35).”
BackgroundReexamination of the Protective Role of the Capsular Polysaccharide (Vi antigen) of Salmonella typhi
Robbins, J. D., & Robbins, J. B. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/150.3.436 · Cited by 247 · cited 1×
“Typhi involves an extracellular phase that renders the pathogen susceptible to Fc receptor-mediated phagocytosis and/or serum-mediated killing (19, 29, 32).”
BackgroundHost adaptation and the emergence of infectious disease: the Salmonella paradigm
Kingsley, R. A., & Bäumler, A. J. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01907.x · Cited by 216 · cited 1×
“Typhi LPS (A) (18) and the repeat unit of the Vi capsular polysaccharide (B) (13) according to previous reports.”
The World Health report 1996--fighting disease, fostering development.
(1997) · PubMed · Cited by 212
Tükel, Ç., Raffatellu, M., Humphries, A. D., Wilson, R. P., Andrews‐Polymenis, H. L., Gull, T., Figueiredo, J. F., Wong, M. H., Michelsen, K. S., Akçelik, M., et al. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04825.x · Cited by 187
Self-citation
Cited by
Interactions of the Human Pathogenic Brucella Species with Their Hosts
Atluri, V. L., Xavier, M. N., de Jong, M. F., den Hartigh, A. B., & Tsolis, R. M. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102905 · Cited by 295
“C3 deposition leads to generation of the anaphylatoxins C3a and C5a, which synergize with TLRs in the induction of proinflammatory cytokines (120, 124).”
BackgroundGunn, J. S., Bakaletz, L. O., & Wozniak, D. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.707547 · Cited by 211
“3 The abbreviations used are: EPS, extracellular polymeric substance; DNABII, DNA binding and bending; eDNA, extracellular DNA; HU, histonelike protein; Pa, Pseudomonas aeruginosa; NTHI, nontypeable Haemophilus influenzae; St/Sty, Salmonella enterica serovar Typhimurium/ Typhi; OM, otitis media; CF, cystic fibrosis; L…”
BackgroundInfluentialPro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9544-0 · Cited by 204
“Activation of CD11b also occurs in macrophages [75], where it is related to opsonic complement-dependent phagocytosis, and a similar modulatory effect on microglial phagocytosis is possible.”
Typhoidal Salmonella: Distinctive virulence factors and pathogenesis
Johnson, R., Mylona, E., & Frankel, G. (2018) · Cellular Microbiology · doi:10.1111/cmi.12939 · Cited by 190
“The Vi capsule inhibits phagocytosis and confers serum resistance (Hart et al., 2016; Wilson et al., 2011), likely by shielding the O‐antigen from antibodies (Hart et al.”
BackgroundTursi, S. A., & Tükel, Ç. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00028-18 · Cited by 162
“(142) and helps bacteria evade the innate immune recognition, thus allowing for the”
Background
Metadata
- Authors
- Wilson, R. P., Winter, S. E., Spees, A. M., Winter, M. G., Nishimori, J. H., Sanchez, J. F., Nuccio, S.-P., Crawford, R. W., Tükel, C., & Bäumler, A. J.
- Affiliations
- University of California, Davis (US)
- Department of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, One Shields Ave., Davis, California 95616-8645
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2011-02
- Volume
- 79
- Issue
- 2
- Pages
- 830-837
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC3028862
- OpenAlex
- W2124392423
- Cited by
- 113
- References
- 39
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 17 · 2017: 4 · 2016: 10 · 2015: 7 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health (1c06rr012088-01)
- University of California, Davis
- National Institute of Allergy and Infectious Diseases (AI088122, R01AI044170, AI 040124, AI044170, R21AI073120, R29AI040124, AI060555, R01AI076246, AI073120, R01AI040124, R21AI088122, AI076246, R37AI044170, T32AI060555)
- National Center for Research Resources (C06-RR012088, C06 RR-12088-01)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- Vi capsular polysaccharide, Salmonella typhi, complement receptor 3, C3 deposition, complement fixation, innate immune recognition, macrophage clearance, opsonization, encapsulation, virulence factors, antibody response
- MeSH terms
- Animals, Carbohydrate Conformation, Complement C3, Immunoglobulin G, Lipopolysaccharides, Liver, Macrophages, Mice, Inbred C57BL, Polysaccharides, Bacterial, Protein Binding, Receptors, Complement, Salmonella Infections, Animal, Salmonella typhi, Spleen, Gene Expression Regulation, Bacterial, O Antigens, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Vi Capsular Polysaccharide Prevents Complement Receptor 3-Mediated Clearance of Salmonella enterica Serotype Typhi. https://app.cochat.ai/papers/10.1128/iai.00961-10
- The paper
- Wilson, R. P., Winter, S. E., Spees, A. M., Winter, M. G., Nishimori, J. H., Sanchez, J. F., Nuccio, S.-P., Crawford, R. W., Tükel, C., & Bäumler, A. J. (2011). The Vi Capsular Polysaccharide Prevents Complement Receptor 3-Mediated Clearance of Salmonella enterica Serotype Typhi. Infection and Immunity. https://doi.org/10.1128/iai.00961-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.